Mou Langming, Wiwatpanit Teerawat, Piriyapol Apiwat, Chawengkul Puwadol, Thaipadungpanit Janjira, Kulchaitanaroaj Puttarin, Teerawattananon Yot, Wang Yi
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Health Intervention and Technology Assessment Program Foundation, Ministry of Public Health, Nonthaburi, Thailand.
Lancet Reg Health Southeast Asia. 2025 Jan 28;33:100533. doi: 10.1016/j.lansea.2025.100533. eCollection 2025 Feb.
Sputum-based diagnostic methods for pulmonary tuberculosis (PTB) are challenging for patients who cannot produce sputum. Non-sputum-based approaches, such as tongue swab (TS), can address this gap. This study conducts an early Health Technology Assessment (HTA) of TS for PTB diagnosis in Thailand.
We conducted a landscape review, stakeholder consultation, early health economic modeling, and established a Target Product Profile (TPP). The landscape review included a comprehensive literature analysis to identify gaps and unmet needs in PTB diagnosis in Thailand. Stakeholder consultations gathered insights from TB experts to validate the information. An early health economic model evaluated the cost-effectiveness of two innovative strategies: tongue swab with Loop-Mediated Isothermal Amplification (LAMP) and tongue swab with real-time polymerase chain reaction (RTPCR). The TPP outlines three target levels to guide innovators in designing effective clinical studies.
The landscape review identified the clinical workflow and reimbursement process of all PTB diagnostic tests in Thailand. The gap of tuberculosis management was around diagnosis and treatment. Stakeholders indicated that PTB detection remains inefficient due to issues such as low-test accuracy, costs, delays, drug-resistance testing, and the need for specialized laboratory techniques and personnel. TS RTPCR is the best-performing strategy, outperforming other strategies for the targeted population from the modelling analysis.
TS may serve as a viable alternative worth further exploration and development. An ongoing collaboration between early HTA researchers and innovators has identified valuable information for innovation development.
This work was supported by Thailand Science Research and Innovation (TSRI), Thailand, Grant Number FFB670043/0401 and Wellcome Trust grant, Grant Number 223800/Z/21/Z.
对于无法咳痰的患者而言,基于痰液的肺结核(PTB)诊断方法颇具挑战性。非痰液检测方法,如舌拭子(TS)检测,可弥补这一不足。本研究针对泰国采用舌拭子进行肺结核诊断展开早期卫生技术评估(HTA)。
我们进行了现状综述、利益相关者咨询、早期卫生经济建模,并制定了目标产品简介(TPP)。现状综述包括全面的文献分析,以找出泰国肺结核诊断方面的差距和未满足的需求。利益相关者咨询从结核病专家处收集见解以验证信息。早期卫生经济模型评估了两种创新策略的成本效益:采用环介导等温扩增技术(LAMP)的舌拭子检测和实时聚合酶链反应(RTPCR)舌拭子检测。目标产品简介概述了三个目标水平,以指导创新者设计有效的临床研究。
现状综述明确了泰国所有肺结核诊断检测的临床工作流程和报销流程。结核病管理的差距主要在诊断和治疗方面。利益相关者指出,由于检测准确性低、成本高、延误、耐药性检测以及对专业实验室技术和人员的需求等问题,肺结核检测效率仍然低下。从建模分析来看,TS RTPCR是表现最佳的策略,优于针对目标人群的其他策略。
舌拭子检测可能是值得进一步探索和开发的可行替代方法。早期卫生技术评估研究人员与创新者之间正在进行的合作已为创新发展确定了有价值的信息。
本研究得到泰国科学研究与创新局(TSRI)的资助,资助编号为FFB670043/0401,以及惠康信托基金会的资助,资助编号为223800/Z/21/Z。